TY - CHAP M1 - Book, Section TI - Chapter 45. Hepatic Colorectal Metastases: Resection, Pumps, and Ablation A1 - Choti, Michael A. A2 - Zinner, Michael J. A2 - Ashley, Stanley W. PY - 2013 T2 - Maingot's Abdominal Operations, 12e AB - Colorectal cancer (CRC) is the third most commonly diagnosed cancer in the United States.1 In spite of an increasing emphasis on screening and prevention of this disease, more than 140,000 new cases will have been diagnosed in 2010, comprising approximately 10% of new cancer diagnoses. Although mortality from this disease has improved over the past two decades, more than 40% of patients with colorectal cancer eventually die of their cancer.1,2 Among those patients with advanced disease, more than half will develop liver metastases, more than any other organ, and many will have disease recognizably confined to this organ. Specifically, approximately 20–40% of patients with metastatic CRC have liver-only metastases at the time of presentation or recurrence, accounting for about 30,000 patients per year in the United States.3,4 SN - PB - The McGraw-Hill Companies CY - New York, NY Y2 - 2024/03/29 UR - accesssurgery.mhmedical.com/content.aspx?aid=57017607 ER -